Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT02475720
Eligibility Criteria:
Inclusion Criteria:
* 1\. EGFR mutation-positive progress recurrent non-small cell lung cancer subject.
* 2\. Subjects who commenced on first-line treatment between January, 2008 and December 2012.
Exclusion Criteria:
* 1\. Patients has a treatment history with the drug which was not approved for marketing authorization as of 31th December , 2014
* 2\. Person who were planning and/or getting involved in this survey. (applies to both AstraZeneca staff and/or staff at the study site)
* 3\. Previous enrolment in the present study.
* 4\. Patient was not evaluated to be appropriate for study enrolment by the investigators
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02475720
Study Brief:
Protocol Section:
NCT02475720